Centrally Acting Drugs has 7 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate, Paliperidone Palmitate, Phenylephrine Hydrochloride. Patients taking Centrally Acting Drugs should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 7
- Major
- 1
- Moderate
- 6
Major (1)
- Centrally Acting Drugs + Sodium Phosphate, Dibasic, Anhydrous, Potassium Phosphate, Monobasic, And Sodium Phosphate, Monobasic, Monohydrate— Concurrent use with sodium phosphate may result in hypernatremia.
Moderate (6)
- Centrally Acting Drugs + Paliperidone Palmitate— Concomitant use may modulate CNS effects of paliperidone palmitate. Use with caution.
- Centrally Acting Drugs + Phenylephrine Hydrochloride— Antagonistic effects decrease phenylephrine blood pressure effect.
- Centrally Acting Drugs + Potassium Phosphate, Monobasic And Sodium Phosphate, Monobasic, Anhydrous— Concurrent use with sodium phosphate may result in hypernatremia.
- Centrally Acting Drugs + Ziprasidone— Caution should be used when ziprasidone is taken with other centrally acting drugs due to primary CNS effects of ziprasi…
- Centrally Acting Drugs + Ziprasidone Hcl— Caution should be used when ziprasidone is combined with other centrally acting drugs due to additive CNS effects.
- Centrally Acting Drugs + Ziprasidone Mesylate— Caution should be used when ziprasidone is taken in combination with other centrally acting drugs due to its CNS effects…